Trial Profile
Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2005-2006 Formulation)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi; Sanofi Pasteur
- 27 Apr 2010 Official Title amended as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual patient number (30) added as reported by ClinicalTrials.gov
- 21 Sep 2008 Actual end date (1 Aug 2007) added as reported by ClinicalTrials.gov.